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Summary
Dendritic cells (DC) are potent accessory cells (AC) for the initiation of primary immune responses.
Although murine lymphoid DC and Langerhans cells have been extensively characterized, DC
from murine lung have been incompletely described. We isolated cells from enzyme-digested
murine lungs and bronchoalveolar lavages that were potent stimulators of a primary mixed
lymphocyte response (MLR). The AC had a low buoyant density, were loosely adherent and
nonphagocytic. AC function was unaffected by depletion ofcells expressing the splenic DC marker,
33D1. In addition, antibody and complement depletion of cells bearing the macrophage marker
F4/80, or removal of phagocytic cells with silica also failed to decrease AC activity. In contrast,
AC function was decreased by depletion ofcells expressing the markers J11d and the low affinity
interleukin 2 receptor (IIr2R), both present on thymic and skin DC. AC function was approximately
equal in FcR+ and FcR- subpopulations, indicating there was heterogeneity within the AC
population. Consistent with the functional data, a combined two-color immunofluorescence
and latex bead uptake technique revealed that lung cells high in AC activity were enriched in
brightly Ia+ dendritic-shaped cells that (a) were nonphagocytic, (b) lacked specific T and B
lymphocyte markers and the macrophage marker F4/80, but (c) frequently expressed C3biR,
low affinity ILr2R, FcRII, and the markers NLDC-145 andJ11d. Taken together, the functional
and phenotypic data suggest the lung cells that stimulate resting T cells in an MLR and that
might be important in local pulmonary immune responses are DC that bear functional and
phenotypic similarity to other tissue DC, such as Langerhans cells and thymic DC.
I
a+ cells with a dendritic shape are widely distributed in
many nonlymphoid tissues such as skin and lung, as well
as in all lymphoid tissue, i.e., spleen, lymph nodes, thymus,
and Peyer's patches (1-14). An Ia+ dendritic cell (DC)l has
been implicated as the principal cell responsible for priming
virgin and resting T lymphocytes in studies that used a pri-
mary allogeneic MLR as a measure of accessory cell (AC)
activity (9, 15, 16).
The lung has a large surface area exposed to the environ-
ment, and local pulmonary immune responses are essential
to protect the host from inhaled microorganisms. It follows,
therefore, that effective APC should exist in the lung. Alve-
olar macrophages (AM) are abundant, but are poor APC in
most species, including mouse and human (17-19). Studies
have demonstrated AC activity in cell populations derived
1 Abbreviations used in this paper. AC, accessory cell; AM, alveolar
macrophages; BAC, bronchoalveolar cells; DC, dendritic cells; GM-
CSF granulocyte/macrophage colony-stimulating factor; IDC,
interdigitating cells; FAd, firmly adherent cells; LAd, loosely adherent
cells; NAd, nonadherent cells.
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from minced, enzyme-digested rat and humanlung, and from
tracheal epithelial digests in the mouse (5, 6, 20-22). In all
ofthese studies, evidence strongly suggested that the AC were
more like splenic DC than macrophages. This evidence is con-
sistent with the identification of Ia+, dendritic-shaped cells
in rat, human, and mouse lung tissue sections (5, 7, 23).
Ia+ DC have not been isolated from whole murine lung, nor
have they been examined for phenotypiccharacteristics other
than Ia. Therefore, theirrelationship to splenic DC and other
types of DC is unclear. An examination of this relationship
is important because it was recently proposed that there are
two distinct populations of DC based on surface markers and
tissue location. DC in one population, represented by splenic
DC, express 33D1, but not the interdigitating cell (IDC)
marker, NLDC-145, or the B cell/thymocyte marker, J11d.
These DC are likely to be located in the marginal zone of
the spleen (24). Peyer's patch DC and nonadherent thymic
DC also express 33D1. The second group of DC, typified
by epidermal Langerhans cells, lack 33D1, but express NLDC-
145 and J11d (12, 25). Collagenase digestion released a loosely
adherent population of DC from the thymus and an addi-
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press these same two markers and lack 33D1 (12). Recent
studies suggest there are functional differences between the
two types of DC with regard to antigen processing and the
ability to prime resting T lymphocytes (26) .
In the current study a mouse pulmonary AC with potent
MLRstimulating capacity was obtained by bronchoalveolar
lavage from airways andby collagenase digestion from lung
interstitium. Like splenic DC, these lung cells had a low
buoyant density, were loosely adherent, and nonphagocytic.
However, a substantial population more closely resembled
Langerhans cells andloosely adherent thymic DC phenotyp-
ically, i.e., they expressedJ11d andNLDC-145, but not33D1.
Materials and Methods
Mice.
￿
C57BL/6 and CBAmice, 7-15 wk oldand ofboth sexes
were from TheJackson Laboratories (Bar Harbor, ME) or Sasco
(Houston, TX).
Antibodies. The mAbs M5/114, which recognizes several la
haplotypes; including IAb(27) and M1/70(28), were from Boehr-
ingerMannheim (Indianapolis, IN). The hybridomas GK1.5 (29),
30-H12 (30), 7D4 (31), 14.8 (32), 25-5-16S (33), andJ11d (34) were
from theAmerican Type CultureCollection (Rockville, MD). The
hybridomas 33D1 (35) and NLDC-145 (36) were gifts from Dr.
Ralph Steinman (The Rockefeller University, NewYork, NY); the
hybridomas 2AG2 (37) and F4/80 (38) were gifts from Dr. Pam
Witte(LoyolaUniversity Medical Center, Chicago, IL); andYTS
169.4 (39, 40) was a gift from Dr. H. Waldmann (University of
Cambridge, Cambridge, UK). Antibody specificities aregivenin
Table2. All mAbs were ratIgG2bexcept for NLDC-145 (rat IgG2a);
J11d and7D4(rat IgM); and25-5-16S (mouse IgM). Controlanti-
bodies included affinity-purifiedrat IgG and the irrelevant mouse
IgMmAbH59, agift from Dr. DorothyYuan (University ofTexas
Southwestern Medical Center, Dallas, TX; 41).
Preparation ofLung Cells.
￿
Mice were injected intraperitoneally
with 150 units heparin (Upjohn Company, Kalamazoo, MI) and
7.5 mg Nembutal (Abbott Laboratories, North Chicago, IL) and
exsanguinated. Bronchoalveolar cells (BAC) were obtained by in-
serting acatheter into the trachea and washing the lungs with at
leastfive 1-ml aliquots ofPBS containing 0.6 mM EDTA. Thepul-
monary vasculature was perfused with sterile saline to remove pe-
ripheral blood cells. The lavaged, perfused lungs were removed,
minced, and incubated at 37°C for 90 min in collagenase and 30
Wg/ml DNase (TypeIV bovine pancreatic DNasel; Sigma Chem-
ical Co., St. Louis, MO). In initial studies, three sources of col-
lagenase were used: (a) Sigma Chemical Co., 150U/ml; (b) Wor-
thington Biochemical Corp. (Type I; Freehold, NJ), 150 U/ml;
and(c) Boehringer-MannheimBiochemicals, (Indianapolis, IN; Cob
lagenase A), 0.7 mg/ml. Different lots of collagenase resulted in
inconsistent yields;therefore, we used thecollagenase sampling pro-
gram offered by Boehringer-Mannheim, and in most studies used
this source ofcollagenase. Digested lung tissue wastapped through
a wire screen, particulate matter was allowed to settle or was re-
movedby rapidfiltration through anylon wool plug, andcells were
washed twice in HBSS (Inland Laboratories, Austin, TX). Lung
cells were separated into density fractions on adiscontinuous Per-
coll gradient (Pharmacia Fine Chemicals, Piscataway, NJ) by sus-
pending cellsin the highest density Percoll, overlaying them with
the lower density Percoll, and centrifuging at 400g for 20 min.
Various fractions were tested for AC activity in an MLR. Pooled
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lowdensity fractions (<1.075 g/ml) were furtherseparated into three
adherence fractions. Cells were incubated in tissue culture dishes for
2 h at 37°C, nonadherent cells (NAd) were removed, and adherent
cellswere incubatedovernight. Thecells that spontaneously detached
during the overnightculturewere called looselyadherent cells (LAd).
Thecellsthat remained attachedaftertheovernight culturewere termed
firmly adherent cells (FAd).
Silica Treatment.
￿
To determineif phagocytic cells were responsible
forAC activity in thelung, LAdwere treatedwith silica particles (0.1
AM; agift from Dr. K.Robock,SteinKohlenberg-Bauverian, 43 Essen-
Krey, FRG). LAdwere incubatedat 37°C for2-4 h with 250Ag/ml
silica in RPMI 1640, 25 mM Hepes (Inland), plus 20% FCS (Gibco
Laboratories, Grand Island, NY). Cells were layered on a Nycodenz
cushion(AccurateChemical andScientific Corp., Westbury, NY, 1.15
g/ml) and centrifuged for 15 min at 1,000g. Viable, nonphagocytic
cells were recovered at the interface; the pellet contained silica-laden
cells, dead cells, and free silica.
EA Rosetting.
￿
LAd were fractionated into FcR' and FcR- cells
by rosettingwith antibody-coated sheeperythrocytes (EA).A 2.5%
solution of SRBC was incubatedwith a subagglutinating dose of
IgGanti-SRBCantibodies (Cordis, Miami, FL) for30 minat 37°C.
TheSRBC were washed twicewith PBSandresuspended to make
a 0.5% solution. Equal volumes of spleen or lung LAd (106/ml)
and the SRBC suspension were mixed and centrifuged at 200g.
This mixturewas incubatedon icefor30 min, gently resuspended,
layered on top of a Percoll cushion (1.075 g/ml), andcentrifuged
at 400 g for 20 min. The rosetted cells (FcR*) and free SRBC
were in the pellet, whilethemajority of nonrosetted cells (FcR-)
were collected at the interface. SRBC in the FcR+ fraction were
lysedby treatment with Tris-ammonium chloride andresidual cells
were washed in HBSS before use.
Depletion ofLAd with mAb and Complement Treatment.
￿
Cells
were incubatedwith 33D1,J11d, 7D4, F4/80, or one of the two
control antibodies for 45 min on ice, washed, and treated for
1 h with baby rabbit serum (Pel-Freez Clinical Systems, Brown
Deer, WI)as asource ofcomplement. Cells were washed in HBSS
before use. When depletingLAdof F4/80-bearing cells, 25 hg/ml
rabbit anti-rat IgG (Jackson Immunoresearch Laboratories, West
Grove, PA) was included in the second incubation.
MorphologyandImmunofluorescence ofLung LAd.
￿
To determine
the phenotype of cells in lung and BAC populations, cells were
first incubatedwith latexparticlesto identify phagocytic cells, then
stained for la alone or in combination with several other mAbs
as shown in Table 1. The cells were incubated for 2 h at 37°C in
a 0.1% solution of 1.1 pm latex particles (Sigma Chemical Co.)
in RPMI containing 20% FCS. Free latex was separatedfrom the
cells by centrifugation over FCS.Cell surfacemarkerswere detected
by indirect or two-color immunofluorescence. Thecells were first
stained with a panel of mAb followed by fluorescein-conjugated
F(ab')z mouse anti-rat IgG, which also recognized thelight chains
o£the IgM mAb(Jackson Immunoresearch Laboratories). Fortwo-
color staining, the cells were then incubated with biotinylated
M5/114, followed by staining with avidinTexas Red (Boehringer-
Mannheim Biochemicals). The cells were examined for latex up-
take and red and green fluorescence using a Zeiss epifluorescent
photomicroscope.
MixedLeukocyte Reaction.
￿
Nylon wool-passed spleen cells (93%
Thy-1.2*, 6% la') from CBA mice (3 x 106/well) were incubated
with various numbers of irradiated AC (2,000 rad) in triplicate in
200 1Al complete RPMI (2 MM L-glutamine, 5 x 10-s M 2-ME,
1 mM sodium pyruvate, 100 U/ml penicillin, 100 Ecg/ml strep-
tomycin, 20 Ag/ml gentamicin) supplemented with 5% heat-
inactivated FCS in flat-bottomed microtiter wells (Costar, Cam-bridge, MA) at 37°C, 5% C02 for 4 d. All cultures contained
1 lzg/ml indomethacin (Sigma Chemical Co.) and 250 U/ml cata-
lase (Worthington Biochemical Corp.). 18 h before harvesting, 0.5
ACi [3H]TdR (Amersham Corp., Arlington Heights, IL) was
added to each well. Cultures were harvested with an automated
cell harvester and analyzed in a liquid scintillation counter.
Results
DensityGradientFractionation ofACfrom Minced, Enzymat-
ically Digested Lungs. la' DC have been identified in frozen
sections of rat, human, and mouse lungs and subsequently
partially enriched in enzymatically digested lungs from rat
and man (5-7, 42). We attempted to isolate DC from mouse
lung by exploiting characteristics described for murine splenic
DC (8). BAC were obtained by bronchoalveolar lavage and
the pulmonary vasculature was perfused to remove blood cells.
The remaining lung tissue was carefully dissected free of the
trachea and Mar region, including the mainstem bronchi,
before preparing the cell suspensions to avoid contamination
with LN cells. Cell suspensions were fractionated on discon-
tinuous Percoll density gradients. Four fractions were tested
for stimulatory activity in an MLR. The high density frac-
tion oflung cells (p > 1.075 g/ml), which consisted primarily
of lymphocytes, had little stimulatory activity (Fig. 1 A).
All three fractions with densities <1.075 g/ml were enriched
in AC activity; thus, in subsequent experiments a single low
density fraction (1.035-1.075 g/ml) was collected. This low
density fraction contained -35% of the total lung cells.
When BAC were fractionated, cellswere present in only the
two high density fractions (>1.075 and 1.050-1.075 g/ml).
No enrichment was seen in either ofthese fractions (Fig. 1 B).
Adherence Pmperties of the Lung AC.
￿
Differential adher-
ence properties have been useful in separating murine DC
from other cell types, including macrophages and lympho-
cytes. Mouse splenic DC are loosely adherent while mouse
Peyer's patch DC and Langerhans cells are nonadherent (12,
14, 43, 44). The low density minced lung cells or the unfrac-
tionated BAC were separated into NAd, LAd, and FAd and
tested for AC activity in an MLR. LAd from both minced
lung and BAC were enriched in AC activity (Fig. 2). LAd
comprised -10% of both the low density lung cells and total
BAC. NAd were also somewhat enriched in AC activity, while
the FAd had little activity. There was a concern that scraping
cells with a rubber policeman might damage them and re-
duce AC activity; therefore, in some experiments (including
the one shown in Fig. 2), FAd that had not been mechani-
callydislodged were used. The low density lung cells or BAC
were initially plated in microtiter plates and incubated over-
night. All nonadherent cells were removed, counted, and sub-
tracted from the number of cells originally placed in the wells
to determine the number of FAd remaining in the wells.
Results were similar to other experiments where FAd were
obtained by scraping the tissue culture dishes with a rubber
policeman.
Composition ofLung andBACPbpulations.
￿
Unfractionated
cells and LAd from lung and BAC were examined by phase
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Figure 1.
￿
Comparison of the Percoll density fractions from lung
and BAC in stimulating an MLR. A representative experiment from
a total of five is shown. T cell-enriched spleen cells (3 x 105/well)
from CBA mice were used as responders. Lung cells from enzyme-
digested lungs (A) and BAC (B) were fractionated on discontinuous
Percoll gradients. Fractions were: <1.04, 1.04-1.05, 1.05-1.075, and
>1.075. Cells from BAC were found in only the two high density
fractions. [3H]TdR incorporation for responder cells alone was 7,000
cpm.
and fluorescence microscopy to determine the cell types present
in each population. It was essential to characterize the Ia+
cells because they are the principal stimulators of an MLR.
Cells were incubated with latex particles to distinguish mac-
rophages from other cell types and stained for la by indirect
immunofluorescence. There was an increased percentage of
Ia+ cells in LAd from both lung and BAC as compared to
unfractionated cells (Table 1). The majority of Ia+ cells in
both lung and BAC LAd were nonphagocytic dendritic-shaped
cells. These cells were easily distinguished, from other la"
cells, not only by their characteristic dendritic shape, but also
by the extreme intensity of the Ia staining (Fig. 3). Because
ofthe low numbers ofLAd obtained from BAC, further studies
concentrated on identifying and characterizing the AC from
minced lung rather than BAC.
Silica Treatment.
￿
Because phagocytosis of latex particles
distinguished lung macrophages and DC, silica was used to
deplete macrophages (16, 45, 46). Lung LAd were incubated
with silica for 2-4 h. Preliminary studies demonstrated that
shorter incubation times did not alter AC activity of lung
LAd but were also insufficient to deplete phagocytic cells.
Nonphagocytic LAd were enriched in AC activity as com-
pared with untreated LAd (Fig. 4). Indirect immunofluores-
cent staining demonstrated a two- to fourfold enrichment
B BAC
>1 .075
_1 .05- 1 .075
12.5 25
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Figure 2.
￿
Comparison of adherence fractionated cells from lung
and BAC in stimulating an MLR. A representative experiment from
a total of four is shown. Low density lung cells (A) or BAC (B)
were compared with NAd, LAd, and FAd. [3H]TdR incorporation for
responder spleen cells alone was 7,642 cpm.in the percentage of Ia+ DC after silica treatment (Untreated
LAd, 19 ± 7% DC; silica-treated LAd, 40 ± 9% DC; n
= 4). Thus, silica treatment confirmed that the cells in LAd
expressing AC function were not classical macrophages.
Fractionation ofLung AC Using Fc Receptor Expression.
￿
DC
in the spleen do not express FcR, thus, antibody-coated SRBC
have been used to separate the FcR- DC from macrophages,
which are FcR+ (43). In contrast, Langerhans cells express
FcR, and mouse tracheal DC have been reported to be FcR+
using the mAb 2AG2, which recognizes the murine FcRII
(5, 47) . Lung cells were fractionated into FcR+ and FcR-
populations by rosetting lung LAd with IgG-coated SRBC
(EA) . Spleen LAd were treated similarly to verify the reli-
ability of the method. Fck- cells in the spleen were enriched
in AC activity, while FcR+ cells were relatively depleted
(Fig. 5) . In four experiments, no difference in AC activity
was seen when comparing FcR+ and FcR- subpopulations
from lung LAd. Indirect immunofluorescence demonstrated
similar percentages of la' DC in rosetted and nonrosetted
populations. In a representative experiment, 79% of the
rosetted DC stained with 2AG2, compared with only 7%
of the nonrosetted DC, verifying that the majority of FcR+
DC rosetted and the majority of FcR- DC did not. These
results indicated that lung DC were heterogeneous in the
expression of FcR.
Effect ofDepleting LAd of Cells that Express 33131, F4/80,
J11d, and Low Affinity IL-2R on AC Function. The mAb 33131,
in the presence of complement, depletes AC activity from
splenic and Peyer's patch cells, but has no effect on the AC
activity of Langerhans cells (14, 15, 44). Treatment of lung
LAd with 33131 and complement failed to deplete AC ac-
tivity, although similar treatment markedly decreased the ca-
pacity of splenic LAd to stimulate an MLR . (Fig. 6). The
mAb F4/80 recognizes freshly isolated Langerhans cells (as
well as most macrophages), but not splenic or thymic DC.
When lung LAd were incubated with F4/80 followed by a
secondary antibody (to facilitate complement fixation) and
complement, AC activity was slightly increased (Fig. 7) . In
a typical experiment, F4/80 and complement treatment de-
creased F4/80+ cells from 44 to 9% and increased the per-
Table 1.
￿
Percentage of la' Cells in Lung and BAC Populations
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centage of DC from 8 to 17%. However, in the experiments
usingF4/80, cell numbers were not readjusted after antibody
and complement treatment and the absolute numbers of Ia+
DC were unchanged. Therefore, the slight increase in the
MLR demonstrated that the cells killed by the treatment had
no positive effect on the MLR. Although B cells made up
a very small percentage of LAd (typically 2-7%), it was im-
portant to demonstrate these cells were not contributing to
the AC activity in lung LAd. Murine B cells are recognized
by the mAb 14.8. Removal ofB cells by panning or comple-
ment lysis with this mAb did not change AC activity. Both
methods were effective at depleting Ig+ cells to undetectable
levels (data not shown). Thus, lung AC did not express typ-
ical markers for splenic DC (33131), freshly isolated Langer-
hans cells or macrophages (F4/80), or B cells (14.8).
The mAb J11d recognizes a cell surface marker on many
cells including most B cells, thymocytes, thymic DC and
Langerhans cells, but not splenic DC. When lung LAd were
treated withJ11d and complement, AC activity was decreased
40%, suggesting that a portion of the lung AC express the
J11d marker (Fig. 8). In one experiment, J11d and comple-
ment treatment was shown to decrease the percentage of Ia+
DC from 23 to 9%. As expected, splenic AC activity was
unaffected by this treatment (data not shown). Both splenic
and thymic DC express low affinity I1r2R, recognized by
the mAb 7134. When lung LAd were treated with 7134 and
complement, AC activity was decreased 63% (Fig. 8). In this
set of experiments, treatment of LAd with anti-la and com-
plement as a control resulted in a 68% decrease in the MLR.
In one experiment, treatment with 7134 or anti-la and com-
plement reduced la+ DC from 23% to 5 and 7%, respec-
tively. In summary, the majority of lung AC activity was
expressed by J11d and low affinity IIr2R+ cells.
Phenotype of Lung DC.
￿
The percent of Ia+ DC that ex-
pressed various markers previously used to characterize mac-
rophages, DC, and other leukocytes was determined (Table
2) . Two-color immunofluorescence showed that the Ia+ DC
did not express the macrophage/Langerhans cell marker F4/80,
the T lymphocyte markers, Thy-1.2, CD4, and CD8, or the
B cell marker recognized by the mAb 14.8. Over half the
The data shown are the percentages of la+ cells in each population as determined by indirect immunofluorescence, n - 3.
` Average number of cells obtained per mouse.
t Determined by uptake of three or more latex particles.
5 Nonphagocytic, dendritic-shaped cells.
II Non-phagocytic, non-dendritic-shaped cells, which likely include B lymphocytes and weakly phagocytic macrophages.
I Relative capacity to serve as stimulators of a primary allogeneic MLR. See Figs. 1 and 2.
Cell yield
per mouse` Total la'
la+
Macrophagest
la+
DC§
la+
Otherll
MLR
stimulation)
Lung 107 15 ± 6 1±1 1±2 13±5 +
Lung LAd 2 x 105 30 ± 7 4±1 18 ± 3 7 ± 5 +++
BAC 106 2 ± 1 1±1 1±2 <1 -
BAC LAd 105 8 ± 3 <1 6±3 2±1 +++la' DC expressed J11d (67%), FcRII (53%), CAR (61%),
and the low affinity IIr2R (81%). The IDC marker NLDC-
145 was clearly detected on 40% of the la+ DC. Because
NLDC-145 staining was particularly faint, it was difficult
to distinguish from the bright la staining ; thus, 40% is a
minimal percentage .
Discussion
This study demonstrated that enzyme-digestion of mu-
rine lung released cells that expressed a potent primaryMLR
stimulating capacity. Various fractionation procedures designed
to separate the potentialAC candidates led to the conclusion
Accessory Cells (x10-3)
Figure 4.
￿
Comparison of untreated and silica-treated lung LAd . A
representative experiment of six is shown . Lung LAd were incubated
with silica particles and live cells collected on a Nycodenz gradient .
l3H]TdR incorporation for responder cells alone was 618 cpm .
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Figure 3.
￿
Phase and fluorescent micro-
graphs of two typical pulmonary DC . LAd
were treated with latex particles for 2 h, fol-
lowed by indirect immunofluorescence to de-
tect Ia . The phase micrographs (A and C)
show the dendritic shape and absence of
phagocytosed latex particles . The fluorescent
micrographs (B and D) demonstrate la
staining in fields identical to A and C,
respectively (x 900).
that DC, not macrophages, were responsible for the potent
AC activity. AM, which are poor AC, were removed bybron-
choalveolar lavage before the lungs were processed. These
results confirmed that AM are poor AC ; however, a small
Combined two-color immunofluorescence and latex bead uptake was
used to determine a panel of surface markers on la+, nonphagocytic
DC .
* Averge t SD of at least three separate determinations .
Table 2 . Cell Surface Antigen Expression by Lung LAd
Hybridoma Specificity Percent lung DC
2AG2 FcRII 53 ± 5'
M1/70 C3biR 61 ± 13
F4/80 MO 2 ± 3
NLDC-145 IDC 40 ± 9
7D4 IL-2R (p55) 81 ± 10
Jlld B, thymocytes 67 ± 21
14.8 CD45 (B cells) <2
30-H12 Thy-1 .2 <2
GK1.5 CD4 <2
YTS169.4 CD8 <2Figure 5 .
￿
Comparison of FcR+ and FcR- subpopulations from
spleen and lung LAd in stimulating an MLR . A representative ex-
periment of four is shown. Spleen and lung LAd were incubated
with EA, then rosetted and nonrosetted cells were separated on a,
Fercoll gradient . Data are shown for 2 .5 x 104 AC/well . [3H]TdR in-
corporation of responder spleen cells alone was 5,942 cpm.
subpopulation ofBAC was shown to contain potent stimu-
lators ofanMLR . Depletion of additional macrophages from
the lung cells due to their continued adherence to plastic
resulted in enrichment of AC activity. FAd were relatively
devoid ofAC activity. Further depletion of macrophages by
treatment with silica or with F4/80 and complement resulted
in even greaterMLRstimulating capacity. Thus, it was un-
likely that typical macrophages were responsible for the AC
activity. In contrast to macrophages, DC are generally loosely
adherent, nonphagocytic, and lack F4/80; therefore, we ex-
amined LAd for Ia+ dendritic-shaped cells.
Using a combined latex bead uptake and immunofluo-
rescence technique, nonphagocytic, brightly Ia+ dendritic-
shaped cells were identified in lung LAd. These DC were
virtually undetectable in the unfractionated lung cells, but
comprised -17% oflungLAd and40% of silica-treated LAd.
Two-color immunofluorescence revealed that the majority of
Ia+ lung DC shared several markers with thymic DC and
epidermal Langerhans cells (12, 25) . Simultaneous enrichment
for Ia+ DC and AC activity strongly implicated DC as the
lung AC, and depletion studies with mAb and complement
supported these observations .
Depletion ofJ11d+ cells, which included 67% of the DC,
resulted in a40% decrease in AC activity. Depletion of low
affinity IIr2R+ cells, which included 84% of Ia+ lung DC,
resulted in a 63% decrease in MLRstimulating capacity, a
reduction in activity comparable to treatment with anti-Ia
and complement . In contrast to the spleen, lung AC activity
Figure 6 .
￿
Effect of the mAb 33D1 and complement on the AC ac-
tivity of spleen and lung LAd . A representative experiment from
eight is shown. Spleen and lung LAd were treated with 33D1 and
complement or complement alone. The remaining cells were tested
for AC activity in an MLR using 2.5 x 104 AC/well. [3H]TdR in-
corporation of the responder spleen cells alone was 2,212 cpm .
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Figure 7.
￿
Effect of depleting F4/80-bearing cells on accessory cell
activity in lung LAd. A representative experiment from four is
shown. LAd were treated with either F4/80 or rat IgG for 45 min,
washed, and incubated with rabbit anti-rat IgG and C' for 1 h at
37°C. The remaining cells were tested for AC activity in an MLR .
[ 3H]TdR incorporation for responder cells alone was 1,565 cpm .
was not decreasedby treatment with 33D1 and complement,
consistent with reports that manyDC found outside the spleen
do not express 33D1 (12) . These results raise three impor-
tant questions : (a)Why are lungDC heterogeneous? (b) Why
are lungDC difficult to purify to homogeneity? and (c) What
is the role for DC in pulmonary immunity?
The heterogeneity in surface marker expressionamong lung
DC is shown in Table 1 . One trivial explanation for this het-
erogeneity is incomplete re-expression of protease-sensitive
markers after collagenase treatment . However, some of the
markers, such as FcRII, are not protease-sensitive (48, 49) .
Therefore, we propose that the phenotype of a lung DC de-
pends on two factors : (a) the developmental state oftheDC ;
and (b) the location of the DC within the lung . Studies by
others indicate that both of these factors are important (23,
25) . Developmental or maturational changes in phenotype
have been documented for Langerhans cells (discussed in de-
tail below) . DC isolated from epidermis (Langerhans cells)
or tracheal epithelium are likely in the same stage ofdevelop-
ment, and are, therefore, homogeneous. In contrast, DC iso-
lated from whole lung likely include not only resident DC,
but also cells migrating into or out of the lung, which could
contribute to heterogeneity. Relative to site within the lung,
Holt and Schon-Hegrad observed differential expression of
two macrophage markers, ED1 and ED2, by DC in the re-
Figure 8 .
￿
Effect of depleting J11d, I1 :.2R, and la-expressing cells on
AC activity of lung LAd. LAd were treated with J11d, 7D4, 25-5-
165, or H59 as a control plus complement. The remaining cells were
tested for AC activity in an MLR using 2 .5 x 104 AC/well . Data are
expressed as percent of control response (Ab+ C'-treated cpm/control
cpm x 100) t SEM in order to compare results of multiple experi-
ments . Data from two to four experiments were combined : for anti-
la, n - 2 ; for 7D4, n a 3 ; for J11d, n = 4 . [3H]TdR incorporation
for responder cells alone was <10% of control in each experiment .spiratory tract of the rat (23). Specifically, ED1 stained DC
in tracheal epithelium and mucosa, in bronchus-associated
lymphoid tissue, and in airway epithelium; ED2 stained DC
in alveolar walls and the pleura. Both EDl+ and ED2+ DC
were observed in peribronchial and perivascular areas. Within
each of these two subpopulations, there was additional het-
erogeneity in expression of other markers, such as CD4,
C3biR, and OX41. Thus, lung DC isolated in the present
study may include cells analogous to the upper and lower
respiratory tract DC described in the rat as well as DC in
transit to or from a relatively fixed position in the lung, such
as in epithelium and/or loosely organized lymphoid tissue.
The heterogeneity was a hindrance in the attempt to pu-
rify lung DC. Many DC shared markers with lung macro-
phages, such as FcRII and C3biR. In addition, AM expressed
the IDC marker NLDC-145 and lacked C3biR. Attempts
to purify lung DCusinganti-Ia reagents were frustrated be-
cause macrophages and DC tended to aggregate (likely be-
cause macrophage FcR bound the Ig-coated DC). Methods
that resulted in the death of one or the other cell type, such
as silica or mAb and complement treatment were the most
effective ways of analyzing the respectiverolesofmacrophages
and DC in MLRstimulation, but these methods did not allow
comparison of positively and negatively selected cells.
Nevertheless, when a large percentage of DC were depleted,
AC activity was greatly decreased, and when a large percentage
of macrophages were depleted with silica, AC activity was
markedly increased.
A role for DC in the lung can be inferred by: (a) com-
paring lung DC to other types of DC, particularly Langer-
hans cells; (b) considering the location ofDC within the lung;
and (c) analyzing what is known about the initiation of im-
mune responses in the lung. Phenotypically, the majority of
lung DC most closely resemble epidermal Langerhans cells
and a recently isolated population of thymic DC (12, 25).
Crowley et al. (12) suggested there are two types of DC:
(a) a "fixed" DC (33D1-, J11d+, NLDC-145+) located in
tissues such as thymus and skin, as well as in the T cell areas
of spleen and lymph node (IDC); and (b) a "migrating" DC
(33D1+, JIM-, NLDC - -145-), typified by the major popu-
lation of DC isolated from the spleen and thought to be lo-
cated in the marginal zone (24). Lung AC are 33D1- and
many are J11d+ and NLDC-145+, resembling the first group
of DC. Among the fixed or interdigitating type of DC,
epidermal Langerhanscellshave been best characterized. Lang-
erhans cells are thought to process exogenous antigens in the
skin and migrate to draining LN where they activate antigen-
specific T lymphocytes (50). In vitro studies that supported
this concept demonstrated that both the phenotype and func-
tion ofLangerhans cells were altered during culture, presum-
ably analogous to changes seen in vivo during migration to
draining LN. Romani et al. demonstrated that freshly iso-
lated Langerhans cells were efficient at processing and pre-
senting intact myoglobin to T cell clones, but were poor stimu-
lators of a primary MLR (26). However, after 3 d in culture
with keratinorytes or granulocyte/macrophage CSF (GM-
CSF), the Langerhans cells lost their ability to process myo-
globin, and became potent stimulators of a primary MLR.
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la expression was dramatically increased within the first 12-18
h of culture, and FcRII and F4/80 were lost during the first
1-2 d (25). The authors suggested that secretion of GM-CSF
by keratinorytes couldinitiate this maturation process in vivo
after Langerhans cellscame into contact with exogenous an-
tigens. Thus, following antigen processing, Langerhans cell
la expression would increase, resulting in a high density of
specific antigen/la complex on the cell surface. Subsequently,
the Langerhans cell would lose its capacity to process antigens,
including self antigens, and acquire the capacity to activate
virgin and resting T cells in the draining LN. This sequence
of events would provide a very potent and specific activation
signal.
We suggest a similar role for DC in the lung because of
their phenotypic similarities to Langerhans cells. Although
we have not been able to directly address the effect of GM-
CSF on lung DC, we have observed that, similar to bulk
epidermal cell cultures, overnight incubation of lung cells
results in an increased capacity to stimulate an MLR (Data
not shown). Addition of GM-CSF during this incubation
did not further increase the AC function. However, it is pos-
siblethat optimal amounts of GM-CSF are made by the lung
cells, thus additional GM-CSF has no effect. Studies using
anti-GM-CSF during the overnight culture will be required
to directly address the effect of GM-CSF on lung DC.
The fact that both skin and lung have large surface areas
exposed to the environment results in the need for efficient
stimulation of local immune responses. DC in the epithe-
lium lining the airways and alveoli, as well as DC in lung
parenchyma and bronchus-associated lymphoid tissue, may
survey their environment for antigens that have traversed the
epithelium. The hypothesis that lung DC carry processed,
exogenous antigens to draining LN to stimulate immune re-
sponses is consistent with a body ofevidence concerning an-
tibody responses afterlung immunization (51). In several spe-
cies, when SRBC were instilled into the lung a primary
antibody response occurred predominantly in the draining
LN, rather than within pulmonary parenchyma or in sys-
temic lymphoid tissue. Although both AM and polymor-
phonuclear leukocytes can carry antigen to draining LN, neu-
trophils cannot stimulate immune responses and, except in
the guinea pig, there is little evidence that AM can stimulate
primary immune responses (52-54). In contrast, DC are
capable ofstimulating primary immune responses, as demon-
strated by their capacity to stimulate both an autologous and
a primary allogeneic MLR (15, 55).
The ability of murine lung DC to process and present an-
tigens has not been thoroughly examined, although mouse
tracheal DC have been shown to present antigen to T cell
hybridomas (5). Preliminary results suggest that lung LAd
(which have been effectively cultured for 24 h) are superior
to splenic DC in presenting both soluble and particulate an-
tigens to primed LN T cells. However, further purification
of DC will be necessary to determine whether the same cells
that stimulate the MLR are responsible for presenting an-
tigen. It will also be important to determine whether freshly
isolated lung AC, like freshly isolated Langerhans cells, differ
in function from the overnight-cultured cells.References
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